Loading…

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepar...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2008-12, Vol.26 (51), p.6555-6563
Main Authors: Hagenaars, Niels, Mastrobattista, Enrico, Glansbeek, Harrie, Heldens, Jacco, van den Bosch, Han, Schijns, Virgil, Betbeder, Didier, Vromans, Herman, Jiskoot, Wim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3
cites cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3
container_end_page 6563
container_issue 51
container_start_page 6555
container_title Vaccine
container_volume 26
creator Hagenaars, Niels
Mastrobattista, Enrico
Glansbeek, Harrie
Heldens, Jacco
van den Bosch, Han
Schijns, Virgil
Betbeder, Didier
Vromans, Herman
Jiskoot, Wim
description Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.
doi_str_mv 10.1016/j.vaccine.2008.09.057
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66705555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X08013133</els_id><sourcerecordid>3500056621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</originalsourceid><addsrcrecordid>eNqFksFu1DAQhiMEokvhEUCWEJzI4sRx4nAAoapQpEocAImbNbUnu14ce2s7K21flNfBYVet1EtzsTX5_P9jz18ULyu6rGjVvt8sd6CUcbisKRVL2i8p7x4Vi0p0rKx5JR4XC1q3TdlU9PdJ8SzGDaWUs6p_WpxUQjRC8HZR_L1A0GXy5TqvRPlxC8FE74gfyOCnQJx3oDfTDlxCTYwDlcwO5r1Ca4mabJoClhqD2f0HBjuhuwFybC9-IOfDgCrNirO-jyYZ796RuIVkwBIfVuDMDcxVAi5rjON0Wwh-SkjyJq3x8Mev0Bll0j6bESDjFLINUWuwFt0Kyeg12ufFkwFsxBfH9bT49eX859lFefn967ezz5el4h1LZSMarTUwzpu27mveYVvrtuO5PNSArO2ZEsBqCoIiwBXte2ANA952Q9XWyE6LtwfdbfDXE8YkRxPnlwGHfoqybTvK8_cgWPVt39GGZfD1PXCT5-DyJWR25CI309eZ4gdKBR9jwEFugxkh7GVF5RwQuZHHCcg5IJL2Mgckn3t1VJ-uRtR3p46JyMCbIwBRgR0COGXiLZfNm45Wc5ufDhzm190ZDDIqg06hNiFPW2pvHmzl4z0FZU2eLNg_uMd4d2sZa0nljznNc5ipyP65A_YPEJX1-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625832092</pqid></control><display><type>article</type><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><source>Elsevier</source><creator>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</creator><creatorcontrib>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</creatorcontrib><description>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2008.09.057</identifier><identifier>PMID: 18848856</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Administration, Intranasal ; Allergy and Immunology ; Animals ; Antibodies, Viral - blood ; Antigens ; Applied microbiology ; Biological and medical sciences ; Dose-Response Relationship, Immunologic ; Eggs ; Female ; Fundamental and applied biological sciences. Psychology ; Hemagglutination Inhibition Tests ; Immunity, Mucosal ; Immunization ; Immunization - methods ; Immunogenicity ; Immunoglobulin A, Secretory - analysis ; Immunoglobulin G - blood ; Infections ; Influenza ; Influenza A virus - immunology ; Influenza vaccination ; Influenza Vaccines - administration &amp; dosage ; Influenza Vaccines - immunology ; Injections, Intramuscular ; Mice ; Mice, Inbred C57BL ; Microbiology ; Nasal vaccination ; Orthomyxoviridae Infections - prevention &amp; control ; Pandemics ; Production capacity ; Proteins ; Split vaccine ; Subunit vaccine ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaccines, Inactivated - administration &amp; dosage ; Vaccines, Inactivated - immunology ; Vaccines, Subunit - administration &amp; dosage ; Vaccines, Subunit - immunology ; Virosomes ; Virosomes - administration &amp; dosage ; Virosomes - immunology ; Whole inactivated virus</subject><ispartof>Vaccine, 2008-12, Vol.26 (51), p.6555-6563</ispartof><rights>Elsevier Ltd</rights><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Dec 2, 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</citedby><cites>FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20947013$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18848856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hagenaars, Niels</creatorcontrib><creatorcontrib>Mastrobattista, Enrico</creatorcontrib><creatorcontrib>Glansbeek, Harrie</creatorcontrib><creatorcontrib>Heldens, Jacco</creatorcontrib><creatorcontrib>van den Bosch, Han</creatorcontrib><creatorcontrib>Schijns, Virgil</creatorcontrib><creatorcontrib>Betbeder, Didier</creatorcontrib><creatorcontrib>Vromans, Herman</creatorcontrib><creatorcontrib>Jiskoot, Wim</creatorcontrib><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</description><subject>Administration, Intranasal</subject><subject>Allergy and Immunology</subject><subject>Animals</subject><subject>Antibodies, Viral - blood</subject><subject>Antigens</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Immunologic</subject><subject>Eggs</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Immunity, Mucosal</subject><subject>Immunization</subject><subject>Immunization - methods</subject><subject>Immunogenicity</subject><subject>Immunoglobulin A, Secretory - analysis</subject><subject>Immunoglobulin G - blood</subject><subject>Infections</subject><subject>Influenza</subject><subject>Influenza A virus - immunology</subject><subject>Influenza vaccination</subject><subject>Influenza Vaccines - administration &amp; dosage</subject><subject>Influenza Vaccines - immunology</subject><subject>Injections, Intramuscular</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiology</subject><subject>Nasal vaccination</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Pandemics</subject><subject>Production capacity</subject><subject>Proteins</subject><subject>Split vaccine</subject><subject>Subunit vaccine</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaccines, Inactivated - administration &amp; dosage</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Vaccines, Subunit - administration &amp; dosage</subject><subject>Vaccines, Subunit - immunology</subject><subject>Virosomes</subject><subject>Virosomes - administration &amp; dosage</subject><subject>Virosomes - immunology</subject><subject>Whole inactivated virus</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFksFu1DAQhiMEokvhEUCWEJzI4sRx4nAAoapQpEocAImbNbUnu14ce2s7K21flNfBYVet1EtzsTX5_P9jz18ULyu6rGjVvt8sd6CUcbisKRVL2i8p7x4Vi0p0rKx5JR4XC1q3TdlU9PdJ8SzGDaWUs6p_WpxUQjRC8HZR_L1A0GXy5TqvRPlxC8FE74gfyOCnQJx3oDfTDlxCTYwDlcwO5r1Ca4mabJoClhqD2f0HBjuhuwFybC9-IOfDgCrNirO-jyYZ796RuIVkwBIfVuDMDcxVAi5rjON0Wwh-SkjyJq3x8Mev0Bll0j6bESDjFLINUWuwFt0Kyeg12ufFkwFsxBfH9bT49eX859lFefn967ezz5el4h1LZSMarTUwzpu27mveYVvrtuO5PNSArO2ZEsBqCoIiwBXte2ANA952Q9XWyE6LtwfdbfDXE8YkRxPnlwGHfoqybTvK8_cgWPVt39GGZfD1PXCT5-DyJWR25CI309eZ4gdKBR9jwEFugxkh7GVF5RwQuZHHCcg5IJL2Mgckn3t1VJ-uRtR3p46JyMCbIwBRgR0COGXiLZfNm45Wc5ufDhzm190ZDDIqg06hNiFPW2pvHmzl4z0FZU2eLNg_uMd4d2sZa0nljznNc5ipyP65A_YPEJX1-A</recordid><startdate>20081202</startdate><enddate>20081202</enddate><creator>Hagenaars, Niels</creator><creator>Mastrobattista, Enrico</creator><creator>Glansbeek, Harrie</creator><creator>Heldens, Jacco</creator><creator>van den Bosch, Han</creator><creator>Schijns, Virgil</creator><creator>Betbeder, Didier</creator><creator>Vromans, Herman</creator><creator>Jiskoot, Wim</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20081202</creationdate><title>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</title><author>Hagenaars, Niels ; Mastrobattista, Enrico ; Glansbeek, Harrie ; Heldens, Jacco ; van den Bosch, Han ; Schijns, Virgil ; Betbeder, Didier ; Vromans, Herman ; Jiskoot, Wim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Intranasal</topic><topic>Allergy and Immunology</topic><topic>Animals</topic><topic>Antibodies, Viral - blood</topic><topic>Antigens</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Immunologic</topic><topic>Eggs</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Immunity, Mucosal</topic><topic>Immunization</topic><topic>Immunization - methods</topic><topic>Immunogenicity</topic><topic>Immunoglobulin A, Secretory - analysis</topic><topic>Immunoglobulin G - blood</topic><topic>Infections</topic><topic>Influenza</topic><topic>Influenza A virus - immunology</topic><topic>Influenza vaccination</topic><topic>Influenza Vaccines - administration &amp; dosage</topic><topic>Influenza Vaccines - immunology</topic><topic>Injections, Intramuscular</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiology</topic><topic>Nasal vaccination</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Pandemics</topic><topic>Production capacity</topic><topic>Proteins</topic><topic>Split vaccine</topic><topic>Subunit vaccine</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaccines, Inactivated - administration &amp; dosage</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Vaccines, Subunit - administration &amp; dosage</topic><topic>Vaccines, Subunit - immunology</topic><topic>Virosomes</topic><topic>Virosomes - administration &amp; dosage</topic><topic>Virosomes - immunology</topic><topic>Whole inactivated virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hagenaars, Niels</creatorcontrib><creatorcontrib>Mastrobattista, Enrico</creatorcontrib><creatorcontrib>Glansbeek, Harrie</creatorcontrib><creatorcontrib>Heldens, Jacco</creatorcontrib><creatorcontrib>van den Bosch, Han</creatorcontrib><creatorcontrib>Schijns, Virgil</creatorcontrib><creatorcontrib>Betbeder, Didier</creatorcontrib><creatorcontrib>Vromans, Herman</creatorcontrib><creatorcontrib>Jiskoot, Wim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hagenaars, Niels</au><au>Mastrobattista, Enrico</au><au>Glansbeek, Harrie</au><au>Heldens, Jacco</au><au>van den Bosch, Han</au><au>Schijns, Virgil</au><au>Betbeder, Didier</au><au>Vromans, Herman</au><au>Jiskoot, Wim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2008-12-02</date><risdate>2008</risdate><volume>26</volume><issue>51</issue><spage>6555</spage><epage>6563</epage><pages>6555-6563</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract In order to study the influence of antigen composition, spatial organization of antigen and the route of administration, four cell culture-derived, inactivated, nonadjuvanted influenza vaccine formulations, i.e. whole inactivated virus (WIV), split, subunit and virosome vaccines were prepared from a single antigen batch. We directly compared the immunogenicity and efficacy of these vaccine formulations after intramuscular (i.m.) or intranasal (i.n.) administration in mice. Prime and boost vaccination were followed by a potentially lethal homologous aerosol challenge. For all vaccines, the i.m. route induced higher serum humoral immune responses as compared to the i.n. route and protected all mice against challenge at a dose of 5 μg. Upon i.n. immunization only WIV and split vaccines induced detectable IgG titers and partial protection against challenge but only very low HI titers were induced in almost all mice. WIV induced mainly IgG2a/c titers via both routes, whereas split vaccine induced exclusively IgG1 titers via both routes. Subunit and virosome vaccines induced exclusively IgG1 via the i.m. route. Mucosal sIgA levels were only detected after i.n. vaccination with WIV. Furthermore, vaccines containing all viral components (WIV and split vaccine) induced higher serum HI titers and serum antibody titers than subunit and virosome vaccines. The differences in magnitude and quality of immune responses of split and WIV, having the same composition, are likely related to their distinct spatial organization. In conclusion, the direct comparison between WIV, split, subunit and virosomes, shows that the differences in immune responses between these well known influenza vaccines can be explained by both the composition and particulate structure of these vaccine formulations.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>18848856</pmid><doi>10.1016/j.vaccine.2008.09.057</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2008-12, Vol.26 (51), p.6555-6563
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_66705555
source Elsevier
subjects Administration, Intranasal
Allergy and Immunology
Animals
Antibodies, Viral - blood
Antigens
Applied microbiology
Biological and medical sciences
Dose-Response Relationship, Immunologic
Eggs
Female
Fundamental and applied biological sciences. Psychology
Hemagglutination Inhibition Tests
Immunity, Mucosal
Immunization
Immunization - methods
Immunogenicity
Immunoglobulin A, Secretory - analysis
Immunoglobulin G - blood
Infections
Influenza
Influenza A virus - immunology
Influenza vaccination
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
Injections, Intramuscular
Mice
Mice, Inbred C57BL
Microbiology
Nasal vaccination
Orthomyxoviridae Infections - prevention & control
Pandemics
Production capacity
Proteins
Split vaccine
Subunit vaccine
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Vaccines, Inactivated - administration & dosage
Vaccines, Inactivated - immunology
Vaccines, Subunit - administration & dosage
Vaccines, Subunit - immunology
Virosomes
Virosomes - administration & dosage
Virosomes - immunology
Whole inactivated virus
title Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T14%3A45%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Head-to-head%20comparison%20of%20four%20nonadjuvanted%20inactivated%20cell%20culture-derived%20influenza%20vaccines:%20Effect%20of%20composition,%20spatial%20organization%20and%20immunization%20route%20on%20the%20immunogenicity%20in%20a%20murine%20challenge%20model&rft.jtitle=Vaccine&rft.au=Hagenaars,%20Niels&rft.date=2008-12-02&rft.volume=26&rft.issue=51&rft.spage=6555&rft.epage=6563&rft.pages=6555-6563&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2008.09.057&rft_dat=%3Cproquest_cross%3E3500056621%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c573t-484ddda3554629257e62d67584df2ae3693c8a320a80eaab099a343a567f162e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625832092&rft_id=info:pmid/18848856&rfr_iscdi=true